Zetia Sales Data
| Rank 28 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Zetia U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 28 | $444,731 | 4.04% | 1,888 | -3.33% |
| Q3 2013 | 28 ( 1) |
$427,471 | 7.25% | 1,953 | -1.81% |
| Q2 2013 | 29 (2) |
$398,591 | 0.89% | 1,989 | -0.30% |
| Q1 2013 | 31 (1) |
$395,066 | 5.27% | 1,995 | 0.86% |
| Q4 2012 | 32 (4) |
$375,281 | 4.04% | 1,978 | 1.33% |
| Q3 2012 | 36 (7) |
$360,711 | 7.06% | 1,952 | 1.72% |
| Q2 2012 | 43 (3) |
$336,926 | 2.52% | 1,919 | -1.69% |
| Q1 2012 | 46 | $328,653 | 2.67% | 1,952 | 0.41% |
| Q4 2011 | 46 ( 2) |
$320,115 | 2.80% | 1,944 | -0.10% |
| Q3 2011 | 44 (4) |
$311,388 | -7.20% | 1,946 | -4.00% |
| Q2 2011 | 40 (2) |
$335,530 | 1.10% | 2,027 | -0.10% |
| Q1 2011 | 42 | $331,879 | n/a | 2,029 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
